SEC Filings

SEC Filings

Email page PDF view Print view Email Alert Social media sharing

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
8-K 8-K 5/11/2017 5/11/2017
Abstract: 8-K filed by RXi Pharmaceuticals (RXII) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-Q 10-Q 5/11/2017 3/31/2017
Registration Statement POS AM 5/4/2017
8-K 8-K 5/1/2017 4/29/2017
Abstract: 8-K filed by RXi Pharmaceuticals (RXII) covering Other Events and Financial Statements and Exhibits.
Proxy DEF 14A 4/27/2017 6/6/2017
Proxy DEFA14A 4/27/2017
8-K 8-K 4/18/2017 4/14/2017
Abstract: 8-K filed by RXi Pharmaceuticals (RXII) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers and Financial Statements and Exhibits.
Proxy PRE 14A 4/12/2017 6/6/2017
8-K 8-K 3/30/2017 3/30/2017
Abstract: 8-K filed by RXi Pharmaceuticals (RXII) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-K 10-K 3/30/2017 12/31/2016
8-K 8-K 3/29/2017 3/29/2017
Abstract: 8-K filed by RXi Pharmaceuticals (RXII) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K 8-K 3/28/2017 3/28/2017
Abstract: 8-K filed by RXi Pharmaceuticals (RXII) covering Regulation FD Disclosure and Financial Statements and Exhibits.
13-D SC 13G 2/14/2017
13-D SC 13G 2/14/2017
13-D SC 13G/A 2/13/2017
8-K 8-K 2/3/2017 2/2/2017
Abstract: 8-K filed by RXi Pharmaceuticals (RXII) covering Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
Registration Statement S-8 2/2/2017
Registration Statement S-8 2/2/2017
13-D SC 13G 1/12/2017
13-D SC 13G/A 1/12/2017

Displaying 1 to 20 (of 151 filings)